Klin Farmakol Farm. 2013;27(1):6-10

Evaluation of lifestyle of the general public in relation to cardiometabolic risk in metabolic syndrome - a pilot project

Daniela Mináriková1, Hana Grešnerová2, Peter Minárik3, Ivona Malovecká1, Viliam Foltán1
1 Farmaceutická fakulta, Katedra organizácie a riadenia farmácie, Univerzita Komenského v Bratislave

Objective of the study: The purpose of the study was to evaluate the acceptance of the commonly recommended rules for a healthy

lifestyle among the general public. This should be part of the prevention of cardiometabolic risk in metabolic syndrome.

Methods: A questionnaire survey of 100 respondents was carried out from January 2011 till March 2011. All the data from the respondents

were processed using Microsoft Excel 2010.

Results: Up to 90 % of the respondents consciously think about prevention, with 66 % of them making an effort to practise a healthy

lifestyle; 53 % report regular physical activity; and 74 % consume fruit and vegetables on a daily basis. Only 15 % of the respondents

reported use of dietary supplements. The acceptance rate of a healthy lifestyle was highest in younger age groups, in women, and in

the population of bigger cities. Especially respondents with fewer health risks perceive healthy lifestyle as prevention.

Conclusion: The pilot project validated a questionnaire method to evaluate the lifestyle of the general public. The pharmacist can play

a role of a specialist consultant in the prevention of cardiometabolic risk of patients by influencing their lifestyle, particularly in terms

of a rational and beneficial use of dietary supplements.

Keywords: metabolic syndrome, healthy lifestyle, prevention of cardiometabolic risks, dietary supplements

Published: May 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mináriková D, Grešnerová H, Minárik P, Malovecká I, Foltán V. Evaluation of lifestyle of the general public in relation to cardiometabolic risk in metabolic syndrome - a pilot project. Klin Farmakol Farm. 2013;27(1):6-10.
Download citation

References

  1. Lietava J, Kosmálová V, Turek P. New Metabolic Syndrome in Slovakia, Bratislava 2011; 8-12.
  2. Galajda P. Etiopatogenetické aspekty metabolického syndrómu, Interná medicína 2006; 5: 273-276.
  3. Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as a predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003; 26: 1177-1184. Go to original source... Go to PubMed...
  4. Sattar N, Gaw A, Scherbakova O. Metabolic syndrome with and without C-reactive protein as a predictor of coronary herat disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-419. Go to original source... Go to PubMed...
  5. Alberti KGM, Zimmet PZ, Shaw J. Metabolic syndrome - a new world-wide definition. A Concensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480. Go to original source... Go to PubMed...
  6. Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzeland: Health Organization; 1999 (cit. 26. 11. 2012) Dostupné z http://www.whqlibdoc.who.int/.../1999/who_ncd_ncs_99.2.
  7. Executive summary oh the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection evaluation and treatment for high blood cholesterol in adults (Adult treatment panel III). JAMA 2001; 285: 24869-2497.
  8. International Diabetes Federation. The IDF Consensus Worldwide definition of the Methabolic Syndrome. IDF, Brussels 2006 (cit. 23.11.2012) Dostupné z http://www.idf.org/.../ IDF_Meta_def_fina...
  9. Bloomgarden ZT. American Association of Clinical Endocrinologist (AACE) Consesnsus Conference on the Insukin Resistance Syndrome. Diabetes Care 2003; 26: 933-939. Go to original source... Go to PubMed...
  10. Galajda P, Mokáň M, Prídavková D, et al. Prevalencia diabetu a metabolického syndrómu na Slovensku. Via Practica 2008; 21: 13.
  11. Lietava J, Kosmálová V, Husárová V, et al. Liečba metabolického syndrómu na Slovensku - výsledky štúdie NEMESYS. Via Practica 2008; S1: 13.
  12. Zdravotnícka ročenka SR 2010, Národné centrum zdravotníckych informácií, Bratislava 2011; 5-6. (cit. 10.11.2012). Dostupné z http://www.nczisk.sk/Publikacie/Edicia_roceniek/Pages/Zdravotnicka-rocenka-2010.aspx.
  13. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Causes_of_death_statistics/sk#Choroby_obehovej_s.C3.BAstavy, (cit. 1. 10. 2012).
  14. Guy De Backer et al. European guidelines on cardiovascular diseases prevention in clinical practice. Third Jonit Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601-1610. Go to original source... Go to PubMed...
  15. Ilanne-Parikka P. Effect of Lifestyle Intervention on the Occurrence of Methabolic Syndrome and its Components in the Finnish Diabetes Prevention Study. Diabetes Care 2008; 31(4): 805-807. Go to original source... Go to PubMed...
  16. Orchard TJ, et al. The Diabetes Prevention Program Research Group: The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005; 142: 611-619. Go to original source... Go to PubMed...
  17. Esposito K, Marfella R, Ciotola M, Di Palo, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D. Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic SyndromeA Randomized Trial. JAMA 2004; 292(12): 1440-1446. Go to original source... Go to PubMed...
  18. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr. 2007; 85: 910-918. Go to original source... Go to PubMed...
  19. Sonnenberg L, Pencina M, Kimokoti R, Quatromoni P, Nam BH, D'Agostino R, Meigs JB, Ordovas J, Cobain M, Millen B. Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res. 2005; 13: 153-162. Go to original source... Go to PubMed...
  20. Lutsey PL, Steffen LM, Stevens J. Dietary Intake and the Development of the Metabolic Syndrome. The ATtherosclerosis Risk in Communities Study. Circulation. 2008; 117: 754-761. Go to original source... Go to PubMed...
  21. Ferrari CKB. Metabolic Syndrome and Obesity: Epidemiology and Prevention by Physical Activity and Exercise. J. Exerc Sci Fit 2008; 6(2): 87-96.
  22. Juturu V, Gormley JJ. Nutritional Supplements Modulating Metabolic Syndrome Risk Factors and the Prevention of Cardiovascular Disease. Current Nutrition & Food Science. 2005; 1: 1-11. Go to original source...
  23. Graham I. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: Executive Summary. Eur Heart Journal 2007; 28(19): 2375-2414. Go to original source... Go to PubMed...
  24. http://www.ekonom.sav.sk/uploads/journals/AHEAD.pdf. (cit. 3. 12. 2012).




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.